Multiple elements regulate GAD65 transcription

Developmental Neuroscience
C S PinalA J Tobin

Abstract

GAD65 and GAD67, the two forms of GABA-synthesizing enzyme, are usually coexpressed, but their levels are regulated independently. The GAD67 promoter has been described. We have now characterized transcriptional regulatory elements in the 5' flanking region of the GAD65 gene, extending 2.4 kb from the ATG translation initiation site. Primer extension assays revealed that transcription begins at -228 in both adult rat brain and in P19 embryonal carcinoma cells, with additional start sites at -280 in brain and at -360 in P19 cells. These sites are in a GC-rich (72%) region lacking a TATA box. Transient transfection assays revealed that the basal promoter is between -740 and -60, and elements conferring cell-type specificity are further 5'. DNA sequences between -1652 and -1420 can 'silence' transcription from a heterologous promoter. GAD65 and GAD67 promoters share little sequence identity, consistent with differences in their transcriptional regulation.

Citations

Jan 13, 2006·Cell and Tissue Research·Joseph F SanchezWilliam J Freed
Jan 1, 1999·Trends in Pharmacological Sciences·J J Soghomonian, D L Martin
Aug 27, 2010·Cerebral Cortex·Carlos Sánchez-Huertas, Beatriz Rico
Mar 31, 2005·Reproduction : the Official Journal of the Society for the Study of Fertility·P PocarS Hombach-Klonisch
Mar 15, 2012·Transcription·Zhizhong Z Pan
Aug 28, 2002·Diabetes·Gillian C L JohnsonJohn A Todd
Jun 24, 2004·Journal of Neuroscience Research·Clara M ChengCarolyn A Bondy
Apr 29, 2004·Journal of Neuroscience Research·Stella DrachevaVahram Haroutunian
Jul 6, 2000·The Journal of Comparative Neurology·T L DellovadeS A Tobet
Dec 26, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shawn WinerH-Michael Dosch
Aug 11, 2000·Brain Research·A Heicklen-KleinI Ginzburg
Jan 4, 2005·Biochemical Pharmacology·Alvaro PugaYing Xia

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.